Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,122 | 11,196 | 23,872 | 20,920 | 39,039 |
| Marketable Securities | 88,822 | 110,593 | 104,280 | 131,347 | 136,466 |
| Other current assets | 415 | 55 | 154 | 61 | 79 |
| TOTAL | $110,093 | $126,802 | $132,458 | $156,853 | $181,557 |
| Non-Current Assets | |||||
| PPE Net | 78,211 | 76,826 | 76,726 | 74,471 | 60,218 |
| Investments And Advances | 21,080 | 23,591 | 38,100 | 42,698 | 55,554 |
| Intangibles | 1,695 | 2,260 | 2,826 | 3,391 | 3,956 |
| Other Non-Current Assets | 354 | 366 | 330 | 324 | 335 |
| TOTAL | $101,340 | $103,043 | $117,982 | $120,884 | $120,063 |
| Total Assets | $211,433 | $229,845 | $250,440 | $277,737 | $301,620 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 14,880 |
| Accounts payable and accrued liabilities | 7,308 | 6,022 | 8,228 | 11,471 | 6,487 |
| Accrued Expenses | 11,517 | 12,077 | 11,267 | 15,838 | 14,381 |
| Other current liabilities | 1,367 | 1,299 | 1,373 | 1,365 | 1,130 |
| TOTAL | $20,192 | $19,398 | $20,868 | $28,674 | $36,878 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 44 | 4,862 | 5,164 | 5,403 | 5,559 |
| TOTAL | $9,610 | $10,087 | $10,728 | $11,359 | $11,818 |
| Total Liabilities | $29,802 | $29,485 | $31,596 | $40,033 | $48,696 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 79,208 | 78,088 | 79,032 | 79,455 | 79,441 |
| Common Shares | 8 | 8 | 8 | 8 | 8 |
| Retained earnings | -553,778 | -526,046 | -498,713 | -471,455 | -447,486 |
| Other shareholders' equity | -448 | -555 | -381 | -202 | -237 |
| TOTAL | $181,631 | $200,360 | $218,844 | $237,704 | $252,924 |
| Total Liabilities And Equity | $211,433 | $229,845 | $250,440 | $277,737 | $301,620 |